SPROTT INC. - Common Shares (SII)

CUSIP: 852066208

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+76,025
Put/Call ratio
69%
SEC-reported price per share
$43.31
Indexed holders
165
Value change
+$5,035,683
Number of buys
75
Open additional details 1 more signal available
Number of sells
65
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
25,738,211

Security key

852066208

Report period

Q3 2024

Indexed institutions

165

Top holders

10

Ownership snapshot

Top reported holders of SII - SPROTT INC. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Arthur Richards Rule
Disclosed value leader
Arthur Richards Rule
Comparable rows
0/15
Latest evidence
12 Sep 2024
3/4/5 13F Highest disclosed value: $107,567,378 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Arthur Richards Rule has the largest disclosed position value at $107.57M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Arthur Richards Rule's linked filing trail.
Disclosed position value Top 5
Arthur Richards Rule $107.57M
SPROTT INC. $60.08M
ROYCE & ASSOCIATES LP $40.89M
Waratah Capital Advisors Ltd. $32.3M
Praetorian PR LLC $23.57M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Arthur Richards Rule
3/4/5
10%+ Owner
—
mixed-class rows
$107,567,378
5,209,074 shares
mixed-class rows
— 12 Sep 2024
SPROTT INC.
13F
Company
13F
—
denominator unverified
$60,083,918
1,451,653 shares
— 30 Jun 2024
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$40,891,713
986,108 shares
— 30 Jun 2024
Waratah Capital Advisors Ltd.
13F
Company
13F
—
denominator unverified
$32,302,714
779,177 shares
— 30 Jun 2024
Praetorian PR LLC
13F
Company
13F
—
denominator unverified
$23,571,605
569,500 shares
— 30 Jun 2024
NORGES BANK
13F
Company
13F
—
denominator unverified
$18,139,623
438,261 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
165
Shares
9,907,581
Indexed holders
165
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 indexed holders
160
Q3 2024 indexed holders
165
Indexed holder difference
5
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .